Names:
|
Deerfield Mgmt, L.P., Deerfield Management Company, L.P.,
Deerfield Special Situations Fund, L.P., Deerfield Special Situations International Master Fund, L.P.,
Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P.
|
Address:
|
780 Third Avenue, 37th Floor
New York, NY 10017
|
Designated Filer:
|
James E. Flynn
|
Issuer and Ticker Symbol:
|
Dicerna Pharmaceuticals, Inc. [DRNA]
|
Date of Earliest Transaction
Required to be Reported:
|
November 7, 2014
|